This is a Validated Antibody Database (VAD) review about human TRA, based on 49 published articles (read how Labome selects the articles), using TRA antibody in all methods. It is aimed to help Labome visitors find the most suited TRA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TRA synonym: IMD7; TCRA; TRA@

BioLegend
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 1b
BioLegend TRA antibody (BioLegend, IP26) was used in flow cytometry on human samples (fig 1b). Proc Natl Acad Sci U S A (2022) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 1c
BioLegend TRA antibody (Biolegend, 306722) was used in flow cytometry on human samples (fig 1c). Biomark Res (2022) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; 1:100; loading ...; fig 6d
BioLegend TRA antibody (BioLegend, 351732) was used in flow cytometry on human samples at 1:100 (fig 6d). Nat Commun (2021) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human
BioLegend TRA antibody (Biolegend, IP26) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; fig s20
BioLegend TRA antibody (Biolegend, 351705) was used in flow cytometry on human samples (fig s20). Science (2019) ncbi
mouse monoclonal (IP26)
  • other; human; loading ...; fig 7a
  • immunocytochemistry; human; loading ...; fig 7a
BioLegend TRA antibody (BioLegend, IP26) was used in other on human samples (fig 7a) and in immunocytochemistry on human samples (fig 7a). elife (2019) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 1a
BioLegend TRA antibody (BioLegend, 306722) was used in flow cytometry on human samples (fig 1a). Cell (2019) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; fig 2a
BioLegend TRA antibody (Biolegend, IP26) was used in flow cytometry on human samples (fig 2a). Cell Stem Cell (2019) ncbi
mouse monoclonal (3C10)
  • immunohistochemistry - frozen section; human; loading ...; fig 1c5
BioLegend TRA antibody (Biolegend, 3C10) was used in immunohistochemistry - frozen section on human samples (fig 1c5). Arthritis Res Ther (2019) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; fig s1a
BioLegend TRA antibody (Biolegend, 3C10) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; 1:300; loading ...; fig s1a
BioLegend TRA antibody (Biolegend, IP26) was used in flow cytometry on human samples at 1:300 (fig s1a). Nat Commun (2018) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; fig 1a
BioLegend TRA antibody (BioLegend, 351704) was used in flow cytometry on human samples (fig 1a). elife (2018) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; fig s2e
BioLegend TRA antibody (BioLegend, 306708) was used in flow cytometry on human samples (fig s2e). Cell (2018) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; fig 1a
BioLegend TRA antibody (BioLegend, 3C10) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; fig 4c
BioLegend TRA antibody (BioLegend, 3C10) was used in flow cytometry on human samples (fig 4c). Cytokine (2017) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; fig s1a
In order to detail MAIT cell responses to various microorganisms and cytokines, BioLegend TRA antibody (BioLegend, 3C10) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig st1
In order to investigate the effect of PD-1 expression on phagocytosis and tumour immunity, BioLegend TRA antibody (Biolegend, IP26) was used in flow cytometry on human samples (fig st1). Nature (2017) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; fig 1d
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BioLegend TRA antibody (BioLegend, 3C10) was used in flow cytometry on human samples (fig 1d). J Clin Invest (2017) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; fig 3b
BioLegend TRA antibody (BioLegend, 3C10) was used in flow cytometry on human samples (fig 3b). J Immunol (2017) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; fig s5a
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, BioLegend TRA antibody (Biolegend, 3C10) was used in flow cytometry on human samples (fig s5a). Immunity (2017) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend TRA antibody (BioLegend, 351710) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; 1:50; loading ...; fig 2a
In order to measure CD11d expression on lymphocyte subsets using flow cytometry, BioLegend TRA antibody (BioLegend, IP26) was used in flow cytometry on human samples at 1:50 (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize CD8 positive alpha beta gamma delta T cells, BioLegend TRA antibody (BioLegend, IP26) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend TRA antibody (Biolegend, 3C10) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (IP26)
  • immunocytochemistry; human; loading ...; fig 4
BioLegend TRA antibody (BioLegend, IP26) was used in immunocytochemistry on human samples (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; 1:400; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend TRA antibody (Biolegend, IP26) was used in flow cytometry on human samples at 1:400 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 1c
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend TRA antibody (biolegend, IP26) was used in flow cytometry on human samples (fig 1c). J Immunol (2016) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; loading ...; fig e3c
In order to discuss the importance of IL-5 positive Th2 cells to allergies, BioLegend TRA antibody (BioLegend, 3C10) was used in flow cytometry on human samples (fig e3c). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; 1:20
In order to describe the CD161(hi)TRAV1-2(+) TCR repertoire, BioLegend TRA antibody (Biolegend, 3C10) was used in flow cytometry on human samples at 1:20. Hum Immunol (2015) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; fig s1
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend TRA antibody (Biolegend, 3C10) was used in flow cytometry on human samples (fig s1). PLoS Pathog (2015) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; fig 3
In order to evaluate the therapeutic potential of a gammatheta T cell-targeting tribody for tumor immunotherapy, BioLegend TRA antibody (Biolegend, #306706) was used in flow cytometry on human samples (fig 3). Cell Immunol (2015) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human
BioLegend TRA antibody (Biolegend, 306706) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human
BioLegend TRA antibody (BioLegend, IP26) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human
BioLegend TRA antibody (BioLegend, IP26) was used in flow cytometry on human samples . Nat Med (2014) ncbi
mouse monoclonal (3C10)
  • flow cytometry; human; fig 2
In order to study mucosal associated invariant T cells and B cell interactions, BioLegend TRA antibody (Biolegend, clone 3C10) was used in flow cytometry on human samples (fig 2). Front Immunol (2014) ncbi
Invitrogen
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig s14b
Invitrogen TRA antibody (eBioscience, IP26) was used in flow cytometry on human samples (fig s14b). Science (2019) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; fig 7a
Invitrogen TRA antibody (eBiosciences, 12-9986-42) was used in flow cytometry on human samples (fig 7a). Cell (2018) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 2c
In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, Invitrogen TRA antibody (eBioscience, IP26) was used in flow cytometry on human samples (fig 2c). Oncotarget (2016) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...
In order to find a role for Car enzymes in regulating mast cell lineage commitment, Invitrogen TRA antibody (eBioscience, IP26) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 2E
In order to study the contribution of CXCR6/CXCL16 interactions in glycolipid-dependent invariant natural killer cell activation and tumor control, Invitrogen TRA antibody (eBioscience, IP26) was used in flow cytometry on human samples (fig 2E). Oncoimmunology (2016) ncbi
mouse monoclonal (6B11)
  • flow cytometry; human; loading ...; fig 2E
In order to study the contribution of CXCR6/CXCL16 interactions in glycolipid-dependent invariant natural killer cell activation and tumor control, Invitrogen TRA antibody (eBioscience, 6B11) was used in flow cytometry on human samples (fig 2E). Oncoimmunology (2016) ncbi
mouse monoclonal (3A8)
  • immunoprecipitation; human; fig 1
In order to study the assembly of the alphabetaTCR, Invitrogen TRA antibody (Thermo Fisher Scientific, TCR1145) was used in immunoprecipitation on human samples (fig 1). J Biol Chem (2015) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; fig 4
In order to discuss the role of T cells in Rasmussen encephalitis, Invitrogen TRA antibody (eBioscience, IP26) was used in flow cytometry on human samples (fig 4). J Neuroinflammation (2015) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human
Invitrogen TRA antibody (e-Biosciences, IP26) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (6B11)
  • flow cytometry; human; fig S2
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen TRA antibody (eBioscience, 12-5806-42) was used in flow cytometry on human samples (fig S2). Proc Natl Acad Sci U S A (2012) ncbi
Santa Cruz Biotechnology
mouse monoclonal
  • western blot; mouse; 1:1000; loading ...; fig 2b
Santa Cruz Biotechnology TRA antibody (Santa Cruz Biotechnology, sc-515719) was used in western blot on mouse samples at 1:1000 (fig 2b). Nat Commun (2019) ncbi
Beckman Coulter
mouse monoclonal (C15)
  • flow cytometry; human; loading ...; fig 1d
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, Beckman Coulter TRA antibody (Beckman Coulter, C15) was used in flow cytometry on human samples (fig 1d). J Clin Invest (2017) ncbi
mouse monoclonal (C15)
  • flow cytometry; human; loading ...; tbl 1
In order to report the function of CD70-CD27 signaling in patients infected with Epstein-Barr virus, Beckman Coulter TRA antibody (Beckman Coulter, C15) was used in flow cytometry on human samples (tbl 1). J Exp Med (2017) ncbi
mouse monoclonal (C15)
  • flow cytometry; human; loading ...; fig 1a
Beckman Coulter TRA antibody (Beckman Coulter, C15) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (C15)
  • flow cytometry; human; fig s4a
Beckman Coulter TRA antibody (Beckman Coulter, C15) was used in flow cytometry on human samples (fig s4a). J Immunol (2016) ncbi
mouse monoclonal (C15)
  • flow cytometry; human
Beckman Coulter TRA antibody (Immunotech, C15) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (C15)
  • flow cytometry; human
Beckman Coulter TRA antibody (Beckman Coulter, C15) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
Articles Reviewed
  1. Laffey K, Stiles R, Ludescher M, Davis T, Khwaja S, Bram R, et al. Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations. Proc Natl Acad Sci U S A. 2022;119:e2118529119 pubmed publisher
  2. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  3. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed publisher
  4. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed publisher
  5. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed publisher
  6. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  7. Saliba D, Céspedes Donoso P, Balint S, Compeer E, Korobchevskaya K, Valvo S, et al. Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells. elife. 2019;8: pubmed publisher
  8. Baeuerle P, Ding J, Patel E, Thorausch N, Horton H, Gierut J, et al. Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response. Nat Commun. 2019;10:2087 pubmed publisher
  9. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  10. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  11. Koppejan H, Jansen D, Hameetman M, Thomas R, Toes R, van Gaalen F. Altered composition and phenotype of mucosal-associated invariant T cells in early untreated rheumatoid arthritis. Arthritis Res Ther. 2019;21:3 pubmed publisher
  12. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  13. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  14. Lee C, Zhang H, Singh S, Koo L, Kabat J, Tsang H, et al. C/EBPδ drives interactions between human MAIT cells and endothelial cells that are important for extravasation. elife. 2018;7: pubmed publisher
  15. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  16. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  17. Kim M, Yoo S, Kang S, Kwon J, Choi I, Lee C. TNF? and IL-1? in the synovial fluid facilitate mucosal-associated invariant T (MAIT) cell migration. Cytokine. 2017;99:91-98 pubmed publisher
  18. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  19. Gordon S, Maute R, Dulken B, Hutter G, George B, McCracken M, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545:495-499 pubmed publisher
  20. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  21. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  22. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  23. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  24. Izawa K, Martin E, Soudais C, Bruneau J, Boutboul D, Rodriguez R, et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J Exp Med. 2017;214:73-89 pubmed publisher
  25. Chamoto K, Guo T, Scally S, Kagoya Y, Anczurowski M, Wang C, et al. Key Residues at Third CDR3? Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs. J Immunol. 2017;198:1056-1065 pubmed publisher
  26. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher
  27. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  28. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  29. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed publisher
  30. Jung Y, Riven I, Feigelson S, Kartvelishvily E, Tohya K, Miyasaka M, et al. Three-dimensional localization of T-cell receptors in relation to microvilli using a combination of superresolution microscopies. Proc Natl Acad Sci U S A. 2016;113:E5916-E5924 pubmed
  31. Henry E, Sy C, Inclan Rico J, Espinosa V, Ghanny S, Dwyer D, et al. Carbonic anhydrase enzymes regulate mast cell-mediated inflammation. J Exp Med. 2016;213:1663-73 pubmed publisher
  32. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  33. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed publisher
  34. Veinotte L, Gebremeskel S, Johnston B. CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFN? production and tumor control. Oncoimmunology. 2016;5:e1160979 pubmed publisher
  35. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  36. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  37. Feige M, Behnke J, Mittag T, Hendershot L. Dimerization-dependent folding underlies assembly control of the clonotypic αβT cell receptor chains. J Biol Chem. 2015;290:26821-31 pubmed publisher
  38. Held K, Beltrán E, Moser M, Hohlfeld R, Dornmair K. T-cell receptor repertoire of human peripheral CD161hiTRAV1-2+ MAIT cells revealed by next generation sequencing and single cell analysis. Hum Immunol. 2015;76:607-14 pubmed publisher
  39. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  40. Owens G, Erickson K, Malone C, Pan C, Huynh M, Chang J, et al. Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis. J Neuroinflammation. 2015;12:134 pubmed publisher
  41. Oberg H, Kellner C, Gonnermann D, Peipp M, Peters C, Sebens S, et al. γδ T cell activation by bispecific antibodies. Cell Immunol. 2015;296:41-9 pubmed publisher
  42. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  43. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  44. Renauer P, Coit P, Sawalha A. The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin Immunol. 2015;156:19-27 pubmed publisher
  45. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed publisher
  46. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed publisher
  47. Tarbox J, Keppel M, Topcagic N, Mackin C, Ben Abdallah M, Baszis K, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34:594-9 pubmed publisher
  48. Salerno Goncalves R, Rezwan T, Sztein M. B cells modulate mucosal associated invariant T cell immune responses. Front Immunol. 2014;4:511 pubmed publisher
  49. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher